Large Urology Group Practice Association (LUGPA) Regional Meetings 2018
OVERVIEW
Large Urology Group Practice Association (LUGPA) Regional Meetings is organized by Large Urology Group Practice Association (LUGPA) and will be held during Jun 01 - 02, 2018 at InterContinental New York Times Square, New York, United States of America.
The target audience for this medical event is Physician Extenders, Administrators & Urologists.Physician Extenders, Administrators & Urologists. This CME Conference has been approved for a maximum of 6.00 AAPA Category 1 CME Credit
This course will address 3 broad areas — maximizing the role of Advanced Practice Providers in urology practice, establishing subspecialty clinics( advanced cancer clinics, women’s health clinics, and men’s health clinics), and new biomarkers in uro-oncology.
Scope of practice and correct billing practices of Advanced Practice Providers are widely misunderstood nationwide. With Urology being one of the top two shortage specialties, it is imperative that we further the understanding of the role an APP can provide as well as the proper regulatory methods for these activities.
A recent survey published by the NCBI indicated that 36% of patients that were treated by the urologists participating in the study had cancer, and of those patients 64% had prostate cancer. Given the expanding treatment options for treating the patient with CRPC it is a critical time for urologists to seriously consider establishing a clinic in order to provide more continuous care to these patients. Continuous care has proven to be beneficial for the patient, especially in a multidisciplinary clinic. This approach may be increasingly useful as prostate cancer patients now face a complex array of treatment options, including different surgical methods, radiation therapies, and active surveillance. Similarly, there are multiple new therapies for treatment of bladder cancer which promises to shift care of that disease in the same direction. This educational series is designed specifically for individuals who want to establish an advanced cancer clinic, or for those who are currently considering a clinic and wish to better understand the associated costs and benefits.
Conference Objectives are :
• Apply the key elements necessary to establish a business plan in the clinical practice setting to effectively maximize utility of Advanced Practice Providers.
• Apply clinical and management of advanced urologic malignancies for the community practice setting.
• Explain AUA and NCCN Guidelines for FDA approved agents and tests in the management of urologic malignancies for patient clinical benefit.
• Evaluate uncommon signs and symptoms a patient may present in challenging cases and gain a better understanding from the patient perspective.
Additional details will be posted as soon as they are available.
The target audience for this medical event is Physician Extenders, Administrators & Urologists.Physician Extenders, Administrators & Urologists. This CME Conference has been approved for a maximum of 6.00 AAPA Category 1 CME Credit
This course will address 3 broad areas — maximizing the role of Advanced Practice Providers in urology practice, establishing subspecialty clinics( advanced cancer clinics, women’s health clinics, and men’s health clinics), and new biomarkers in uro-oncology.
Scope of practice and correct billing practices of Advanced Practice Providers are widely misunderstood nationwide. With Urology being one of the top two shortage specialties, it is imperative that we further the understanding of the role an APP can provide as well as the proper regulatory methods for these activities.
A recent survey published by the NCBI indicated that 36% of patients that were treated by the urologists participating in the study had cancer, and of those patients 64% had prostate cancer. Given the expanding treatment options for treating the patient with CRPC it is a critical time for urologists to seriously consider establishing a clinic in order to provide more continuous care to these patients. Continuous care has proven to be beneficial for the patient, especially in a multidisciplinary clinic. This approach may be increasingly useful as prostate cancer patients now face a complex array of treatment options, including different surgical methods, radiation therapies, and active surveillance. Similarly, there are multiple new therapies for treatment of bladder cancer which promises to shift care of that disease in the same direction. This educational series is designed specifically for individuals who want to establish an advanced cancer clinic, or for those who are currently considering a clinic and wish to better understand the associated costs and benefits.
Conference Objectives are :
• Apply the key elements necessary to establish a business plan in the clinical practice setting to effectively maximize utility of Advanced Practice Providers.
• Apply clinical and management of advanced urologic malignancies for the community practice setting.
• Explain AUA and NCCN Guidelines for FDA approved agents and tests in the management of urologic malignancies for patient clinical benefit.
• Evaluate uncommon signs and symptoms a patient may present in challenging cases and gain a better understanding from the patient perspective.
Additional details will be posted as soon as they are available.
KEY DATES
01 Jun, 2018
Event Start Date
02 Jun, 2018
Event End Date
SPECIALITIES
UrologySUGGESTED HOTELS
CONFERENCE VENUE
InterContinental New York Times SquareRELATED CONFERENCES & LIVE WEBINARS
Quick Links